Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis b Virus Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07053449
What this trial is testing

The Impact of Treatment for Chronic Hepatitis B Virus on Non-clinical Harms

Who this might be right for
Hepatitis B Virus (HBV)
Nottingham University Hospitals NHS Trust 30
Post-approval studies (Phase 4)Study completedNCT02850848
What this trial is testing

Pharmacokinetics of Two Formulations of Entecavir

Who this might be right for
Hepatitis B
Yung Shin Pharm. Ind. Co., Ltd. 39
Not applicableStudy completedNCT00876148
What this trial is testing

Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting

Who this might be right for
Hepatitis B VirusAllograftHematological Malignancies
Azienda Ospedaliera San Giovanni Battista
Large-scale testing (Phase 3)Study completedNCT00315055
What this trial is testing

Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule

Who this might be right for
Hepatitis BPolioDiphtheria+1 more
Sanofi Pasteur, a Sanofi Company 310
Not applicableUnknownNCT06313255
What this trial is testing

A Retrospective Observational Study on the Effects of Probiotics on HBsAg Clearance

Who this might be right for
Chronic Hepatitis B
Qilu Hospital of Shandong University 40
Not applicableStudy completedNCT02798549
What this trial is testing

HBV Virions Bound Proteins

Who this might be right for
Hepatitis B Virus Infection
Hospices Civils de Lyon 14
Early research (Phase 1)UnknownNCT03244085
What this trial is testing

Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis b
Qilu Pharmaceutical Co., Ltd. 18
Post-approval studies (Phase 4)Study completedNCT00753649
What this trial is testing

Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants

Who this might be right for
Hepatitis BTetanusPoliomyelitis+3 more
GlaxoSmithKline 224
Testing effectiveness (Phase 2)Study completedNCT00627458
What this trial is testing

Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine

Who this might be right for
Acellular PertussisDiphtheriaPoliomyelitis+3 more
GlaxoSmithKline 403
Not applicableStudy completedNCT00146835
What this trial is testing

Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine

Who this might be right for
Hepatitis BPoliomyelitisDiphtheria+2 more
GlaxoSmithKline 120,794
Not applicableUnknownNCT02336399
What this trial is testing

Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon Treatment

Who this might be right for
Chronic Hepatitis B
Beijing Ditan Hospital 420
Large-scale testing (Phase 3)Ended earlyNCT01641926
What this trial is testing

The Safety and Efficacy of Pegylated Inferferon Alfa-2b (PEG-Intron™) Versus Pegylated Interferon Alfa-2a (PEGASYS™) in Participants With Chronic Hepatitis B (P08450)

Who this might be right for
Hepatitis B, Chronic
Merck Sharp & Dohme LLC 402
Post-approval studies (Phase 4)Study completedNCT00329576
What this trial is testing

Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine

Who this might be right for
Hepatitis B
GlaxoSmithKline 632
Not applicableStudy completedNCT02985450
What this trial is testing

A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseHepatitis BVaccine Reaction
University of Calgary 82
Testing effectiveness (Phase 2)Ended earlyNCT04684914
What this trial is testing

HepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB)

Who this might be right for
Hepatitis B, Chronic
Altimmune, Inc. 87
Not applicableStudy completedNCT00834158
What this trial is testing

Efficacy of Sequential TACE and PVE on the Resectability of Hepatitis B Related HCC

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 20
Not applicableStudy completedNCT02548325
What this trial is testing

Prevalence of Hepatitis B in Vallés Occidental. Observational Multicentric Study

Who this might be right for
Hepatitis B
Corporacion Parc Tauli 1,001
Not applicableNo Longer AvailableNCT05683548
What this trial is testing

Replicor Compassionate Access Program

Who this might be right for
Viral Hepatitis BViral Hepatitis DCirrhosis, Liver+4 more
Replicor Inc.
Testing effectiveness (Phase 2)Ended earlyNCT00230490
What this trial is testing

Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201

Who this might be right for
Hepatitis B, Chronic
Bausch Health Americas, Inc. 150
Large-scale testing (Phase 3)Study completedNCT02060058
What this trial is testing

Boceprevir-based Therapy to Rescue HCV Genotype 1/HBV Infected Patients Refractory to Combination Therapy

Who this might be right for
Hepatitis C, Chronic
Kaohsiung Medical University Chung-Ho Memorial Hospital 12
Next Page